The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,098.00
Bid: 9,110.00
Ask: 9,114.00
Change: 120.00 (1.34%)
Spread: 4.00 (0.044%)
Open: 9,066.00
High: 9,144.00
Low: 9,008.00
Prev. Close: 8,978.00
NXT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - NXG/CME

7 Aug 2018 15:30

RNS Number : 0839X
Syquant Capital
07 August 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

NEX Group PLC

 

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

6th August 2018

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

YES - CME Group Inc.

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

17.5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Derivatives (other than options):

4,470,651

1.18

 

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

4,470,651

1.18

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

17.5p ordinary

17.5p ordinary

17.5p ordinary

CFD

CFD

CFD

Increasing a long position

Increasing a long position

Increasing a long position

100,000

26,972

15,000

1012 GBp

1011 GBp

1010.75 GBp

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

7th August 2018

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETSSAFFWFASEFA
Date   Source Headline
1st Jun 20209:47 amRNSTotal Voting Rights
14th May 202012:30 pmRNSResult of AGM
1st May 20209:01 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSTrading Statement
27th Apr 202010:55 amRNSDisclosure of Rights Attaching to Equity Shares
14th Apr 20204:40 pmRNSAnnual Financial Report
14th Apr 20207:00 amRNSNEXT Reopens Online, Warehousing and Distribution
8th Apr 20205:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20206:03 pmRNSCovid Corporate Financing Facility (CCFF)
1st Apr 20205:40 pmRNSDirector/PDMR Shareholding
1st Apr 20209:06 amRNSTotal Voting Rights
27th Mar 20209:34 amRNSHolding(s) in Company
27th Mar 20207:00 amRNSNEXT PLC - UPDATE ON OPERATIONS
24th Mar 20205:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20204:42 pmRNSDirector/PDMR Shareholding
23rd Mar 20201:12 pmRNSHolding(s) in Company
20th Mar 20205:09 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSResults for the Year Ending January 2020
2nd Mar 202010:16 amRNSTotal Voting Rights
13th Feb 20205:32 pmRNSTransaction in Own Shares
12th Feb 20205:13 pmRNSTransaction in Own Shares
11th Feb 20205:07 pmRNSTransaction in Own Shares
10th Feb 20205:32 pmRNSTransaction in Own Shares
7th Feb 20205:32 pmRNSTransaction in Own Shares
6th Feb 20206:10 pmRNSTransaction in Own Shares
3rd Feb 202010:13 amRNSTotal Voting Rights
24th Jan 202010:05 amRNSBlock Listing Interim Review and Cancellation
3rd Jan 20204:21 pmRNSHolding(s) in Company
3rd Jan 20207:00 amRNSTrading Statement
31st Dec 20191:30 pmRNSTotal Voting Rights
30th Dec 20194:01 pmRNSSir David Jones CBE
2nd Dec 20192:00 pmRNSTotal Voting Rights
31st Oct 20195:00 pmRNSTotal Voting Rights
30th Oct 20197:00 amRNSNEXT PLC - Trading Statement
15th Oct 20194:24 pmRNSDirector/PDMR Shareholding
1st Oct 20199:21 amRNSTotal Voting Rights
23rd Sep 20196:18 pmRNSDirector/PDMR Shareholding
20th Sep 20195:00 pmRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSResults for the Half Year Ending July 2019
30th Aug 20193:35 pmRNSTotal Voting Rights
8th Aug 20195:06 pmRNSTransaction in Own Shares
7th Aug 20195:40 pmRNSTransaction in Own Shares
6th Aug 20196:05 pmRNSTransaction in Own Shares
5th Aug 20195:33 pmRNSTransaction in Own Shares
31st Jul 20195:48 pmRNSDirector/PDMR Shareholding
31st Jul 20194:26 pmRNSTotal Voting Rights
31st Jul 20197:00 amRNSTrading Statement
25th Jul 201910:43 amRNSBlock listing Interim Review
15th Jul 20193:20 pmRNSHolding(s) in Company
28th Jun 20194:55 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.